Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 30;10(1):10.
doi: 10.3390/tropicalmed10010010.

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d'Ivoire

Orphée Kangah  1 , Issaka Zongo  2 , Alassane Haro  2 , William Yavo  1
Affiliations

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d'Ivoire

Orphée Kangah et al. Trop Med Infect Dis. .

Abstract

Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3-59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal. In Côte d'Ivoire, malaria remains a high priority and accounts for the majority of consultations and deaths in children under five. The recent revision of the criteria for the introduction of seasonal malaria chemoprevention has made the north of Côte d'Ivoire, where malaria transmission is seasonal, eligible for the SMC. We conducted a pilot study in this part of the country to assess the acceptability and feasibility of five cycles of SMC in 1701 children. Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine + amodiaquine (SP + AQ) was administered monthly to eligible children over five months. A qualitative approach and quantitative surveys were used to assess the strategy acceptability and feasibility in the study area. Overall, there was a positive perception, attitude, and adherence towards the seasonal malaria chemoprevention in this study area.

Keywords: acceptability; feasibility; north Côte d’Ivoire; seasonal malaria chemoprevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of SMC coverage by cycle.
See this image and copyright information in PMC

References

    1. Cairns M., Roca-Feltrer A., Garske T., Wilson A.L., Diallo D., Milligan P.J., Ghani A.C., Greenwood B.M. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat. Commun. 2012;3:881. doi: 10.1038/ncomms1879. - DOI - PMC - PubMed
    1. World Health Organization . WHO Guidelines for Malaria. World Health Organization; Geneva, Switzerland: Feb 16, 2021.
    1. World Health Organization . World Malaria Report 2021. World Health Organization; Geneva, Switzerland: 2021.
    1. M’Bra R.K., Kone B., Soro D.P., N’krumah R.T., Soro N., Ndione J.A., Sy I., Ceccato P., Ebi K.L., Utzinger J., et al. Impact of climate variability on the transmission risk of malaria in northern Côte d’Ivoire. PLoS ONE. 2018;13:e0182304. doi: 10.1371/journal.pone.0182304. - DOI - PMC - PubMed
    1. Ehouman M.A., N’Goran K.E., Coulibaly G. Malaria and anemia in children under 7 years of age in the western region of Côte d’Ivoire. Front. Trop. Dis. 2022;3:957166. doi: 10.3389/fitd.2022.957166. - DOI

LinkOut - more resources